Prevalence of metabolic syndrome during menopausal transition Tehranian women: Tehran Lipid and Glucose Study (TLGS)

被引:35
作者
Ainy, E. [1 ]
Mirmiran, P. [1 ]
Asl, S. Zahedi [1 ]
Azizi, F. [1 ]
机构
[1] Shahid Beheshti Univ Med Sci, Endocrine Res Ctr, Tehran, Iran
关键词
metabolic syndrome; menopause; women; high-density lipoprotein cholesterol;
D O I
10.1016/j.maturitas.2007.07.002
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: This study was conducted to assess the prevalence of metabolic syndrome (MetS) in Tehranian women during menopausal transition. Design: In this cross sectional study 2182 subjects, pre-menopausal (pre-M) n=537, menopausal (M) n=311 and postmenopausal (post-M) n = 1334 were selected from 15005 participants of the TLGS and assessed for MetS risk factors. All MetS components were evaluated following age adjustment according to the ATPIII criteria. Results: The mean ages of post-M, M and pre-M women were 61.0 +/- 4.3, 53.0 +/- 4.0 and 47.0 +/- 1.9 years, respectively. The prevalence of MetS in subjects was 63% (53%, 54% and 69%) in pre-M, M and post-M women respectively. HDL-c levels was significantly higher in post-M women in comparison to pre-M women (p < 0.001). TG levels, FPG and waist circumference was significantly higher in post-M women in comparison to pre-M women (p < 0.05). The most frequent markers of MetS were low HDL-c and high diastolic blood pressure in post-M women. Conclusion: It is concluded that the frequency of MetS is significantly higher in post-M women as compared to pre-M women; low HDL-c and high diastolic blood pressure is the most frequent feature in comparison to other factors. (c) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:150 / 155
页数:6
相关论文
共 35 条
[1]  
Azizi F, 2002, NUTR METAB CARDIOVAS, V12, P80
[2]   Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study [J].
Azizi, F ;
Salehi, P ;
Etemadi, A ;
Zahedi-Asl, S .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2003, 61 (01) :29-37
[3]  
AZIZI F, 2001, 121 NAT LIB IR, P1
[4]  
Azizi F., 2000, CVD PREVENTION INTER, V3, P242
[5]   MENOPAUSAL EFFECTS ON RISK-FACTORS FOR ISCHEMIC HEART-DISEASE [J].
BENGTSSON, C ;
LINDQUIST, O .
MATURITAS, 1979, 1 (03) :165-170
[6]  
Bergmann S, 1997, MENOPAUSE, V4, P52
[7]   MENOPAUSE-RELATED CHANGES IN LIPOPROTEINS AND SOME OTHER CARDIOVASCULAR RISK-FACTORS [J].
BONITHONKOPP, C ;
SCARABIN, PY ;
DARNE, B ;
MALMEJAC, A ;
GUIZE, L .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1990, 19 (01) :42-48
[8]  
Casiglia E, 1996, J HYPERTENS, V14, P729
[9]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[10]   MULTIPLE CORONARY HEART-DISEASE RISK-FACTORS ARE ASSOCIATED WITH MENOPAUSE AND INFLUENCED BY SUBSTITUTIVE HORMONAL-THERAPY IN A COHORT OF FRENCH WOMEN [J].
DALLONGEVILLE, J ;
MARECAUX, N ;
ISOREZ, D ;
ZYLBERBERG, G ;
FRUCHART, JC ;
AMOUYEL, P .
ATHEROSCLEROSIS, 1995, 118 (01) :123-133